Direct Targeting of CXCR2 Receptor Inhibits Neuroblastoma Growth: An In Vitro Assessment.

Pharmaceuticals (Basel) · 2025 · PMC12566611 · PMID 41155662

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the Versteeg dataset did not reach statistical significance, likely due to limited sample size, the consistent and significant associations observed in the three larger cohorts strongly support CXCR2 as a prognostic factor in NB.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.